The distribution of unbound amino acids in the plasma and blood cells of patients with leukemia may be expected to reflect abnormalities in both the concentrating ability of the cells for the amino acids and in the amino acid metabolism. The distribution of unbound amino acids in the plasma and blood cells of normal subjects has been reported in an earlier communication (1) . Studies of the distribution of unbound amino acids in leukemic bloods do not appear to have been previously made, although Kelley and Waisman (2) have studied plasma concentrations and NourEldin and Wilkinson (3) have studied the relative concentrations of several amino acids in the leukocytes of leukemic patients. Some qualitative variations in amino acid concentrations in leukocytes fron also The methods used for collection of the blood and the urine specimens, and for the analysis of the unbound amino acids were the same as those used for normal subjects (1) . All bloods were drawn at the end of an approximate 14 hour fast, and all urines were collected during the last 8 hours of this period.
The notations used for expressing the variability of the data and for expressing the results from tests of different hypotheses are the same as those used previously. The level of significance, a, was established at 0.05. The ,8 error was estimated for each evaluation where a significant difference was detected (1) .
RESULTS
Unbound amino acid concentrations in plasma of leukemic patients a patients with different types of leukemia have
The analyses of 32 plasma specimens from 23 been reported by Rouser (4) .
patients with various types of leukemia are given in Table I 4 8 12 -16 Both the ornithine and urea concentrations were UREA (x 10-3) found to be high in the leukemic plasmas. Except ;.1.COMPARISON OF CONCENTRATIONS OF ORNI-for one patient, J.W., the increase in ornithine E AND UREA IN PLASMA OF LEUKEMIC PATIENTS. concentration correlated very well with the in-)moles per kilogram of water; line drawn by least crease in plasma urea values (see Figure 1 ).
es.
The product moment correlation coefficient, R, ided by Grant C-2497 from the National Cancer calculated for a correlation between ornithine and ute, Bethesda, Md. urea concentrations in plasma was found to be 1688 t Taken from reference (1) .
t Standard deviation of the mean. § The mean value for arginine in chronic granulocytic leukemia (55 ± 6.6) was significantly lower than the mean value in chronic lymphocytic leukemia (85 ± 4.6).
If Less than 50 in the other patient analyses.
highly significant, with a probability of correlation equal to 0.999. Patient J.W. (assay G13), in whom the ornithine concentration was normal but the urea concentration very high, had renal insufficiency and therefore was not necessarily producing large amounts of urea. Plasma urea levels of this patient were 26,000 ,umoles per kg water compared with a normal value of 5,380; the excretion rate of urea was 3,800 jsmoles per hour compared with a normal excretion of 11,450. Ethanolamine' was found in eight specimens of plasma from eight patients; it was never found in any of the analyses of normal subjects. ,8-Amino isobutyric acid was found in two analyses (G13 and Li). This substance also was not found in the plasma of normal subjects and we know of no reports of its being found by others. The only substance in low concentration in the plasma of the patients was alanine. Arginine concentrations were observed to be low in the plasma of chronic granulocytic leukemic patients by Kelley and Waisman (2) . Our determinations of arginine in such patients were somewhat lower, but not significantly lower than the arginine values found in normal subjects (1) . In chronic lymphocytic leukemia the arginine concentrations tended to be slightly higher than those found in normal subjects. Comparison of the means of the arginine values of these two groups of patients showed their differences to be significant.
Kelley and Waisman also reported significantly higher values for proline and phenylalanine in leukemic patients. The mean concentrations for these two substances in our patients were moderately higher but not significantly higher than those found in normal subjects. High concentrations of glutamic acid and alanine in chronic leukemic patients or low concentrations of threonine and high concentrations of tyrosine in acute leukemic patients, which had been observed by Kelley and Waisman (2) , were not found in the current study.
Unbound amino acids in erythrocytes of leukemic patients The concentrations of unbound amino acids found in the erythrocytes are presented in Table  II (assays G9 and L18 were lost). The erythrocyte-plasma ratios are presented in Table III ( G4, 7, 11, 13, L8, 15, G4, 5, 7, 12, 13, L2, 3, 5, 8, 10a, 12, 15-17 Taurine 31 <245 ± 110 H 0 G1, 4, 7, 10-13, L3, 12, 13, 15-17 cytes. The very high levels of glutamic acid found in the erythrocytes will be further discussed below. Iyer (5) has reported marked increases in concentrations of alanine, glutamic acid, glutamine, and serine plus glycine in red cells of patients with iron deficiency anemia. There was no evidence that any of our patients had iron deficiency anemia but several of them had moderate to severe anemia associated with their leukemia. The specimens of anemic patients showed no consistent variation from the specimens of patients with no anemia with regard to any of the amino acids.
The concentrations of ergothioneine found in the erythrocytes of the patients with chronic granulocytic leukemia were much lower than those found in other leukemic patients or in normal subjects. Since almost nothing is known of ergothioneine function in mammalian cells the significance of this striking difference is not clear.
Abnormal concentrations of leukocyte amino acids which were common to most of the leukemic patients Changes in concentration of four substances in the leukocytes of the patients, when compared with normal subjects, were characteristic of leukemia without regard to the kind of leukemia and, except for treatment with Chloramibucil,' were independent of the type of treatment (see Tables  IV, V , VI and VII). These were O-phosphoethanolamine, glutamic acid, proline and ornithine. Discussions of each of these follow.
0-phosphoethanolamine concentrations were found to be very high in the leukocytes of most leukemic patients; values higher than the normal means were found in every patient sample in which 0-phosphoethanolamine was measured. All untreated chronic lymphocytic leukemic patients, acute granulocytic leukemic patients, and monocytic leukemic patients had O-phosphoethanolamine concentrations which were higher by more than 2 SD of the normal mean. It was also high in patients after treatment with X-ray, TEM 2 and nitrogen mustard.3 Its concentration tended to be less high in chronic granulocytic patients; only one patient in six (Gl) had values higher than 2 SD of the normal mean. 0-phosphoethanolamine was not determined in the leukocytes of Patients G3, 4, 7 and 8. Its concentration was normal in two cases after treatment with Chlorambucil. Elevated concentrations of O-phosphoetha-nolamine had previously been observed by NourEldin and Wilkinson in the leukocytes of some leukemic patients (3) . In addition to this, Outhouse (6) as early as 1936, had found increased amounts of 0-phosphoethanolamine in many malignant tissues. It is also highly significant that other patients, such as those with leukemoid reaction, polycythenlia vera, leukocytosis following accidental cobalt-radiation, malignant carcinoid, congenital anemia, spherocytosis and general emaciation did not show elevated 0-phosphoethanolamine levels. 4 Glutamic acid concentrations had been found to be elevated in the leukocytes of leukemic patients by . In the present study the mean concentration for glutamic acid in the granulocytic, monocytic and untreated chronic lymphocytic leukemic patients was more than twice as high as the mean concentration found in normal subjects. In 13 of the 24 patients in these categories glutamic acid analyses were higher than the normal mean by more than 2 SD. Leukocyte gluttamic acid concentrations were also very high in two analyses conducted on a patient one and two days after extensive irradiation. On the other hand, only one of the six patients under treatment with chemotherapeutic agents had an elevated glutamic acid value. The high glutamic acid values in the leukocytes in conjunction with the high concentrations in the erythrocytes of these leukemic patients emphasizes that the metabolism of this amino acid is critically affected in leukemia.
High glutamic acid values have also been noted in other malignant tissues (7, 8) . It was not found to be characteristically elevated in either the erythrocytes or leukocytes of the nonleukemic patients listed above.
Proline concentrations also were high in the leukocytes of the leukemic patients, particularly when compared with the concentrations of the other amino acids. It was higher than 2 SD of the normal mean in five patients with granulocytic leukemia (category a, see below); it was low in concentration in only one patient, that of assay L3, where the unbound amino acid concentrations were almost all very low. Proline concentrations were also elevated in the erythrocytes of the leukemic patients (Table II) . Since glutamic acid and proline have interrelated pathways of metabolism (9), a correlation study by regression analysis was conducted. This study did not, however, support a relationship between these two substances in either the erythrocytes or leukocytes.
Low ornithine concentrations were observed in the leukocytes of many of the leukemic patients. Ornithine was elevated in assays of only two patients, L6 and L8. However, in both of these analyses the other amino acid concentrations were increased severalfold. Ornithine concentrations were less than 2 SD of the normal mean in 15 analyses out of 29. This low level of ornithine in the leukocytes becomes even more striking in view of the higher than normal concentrations of ornithine found in-the plasma and erythrocytes of these same patients.
Arginine concentrations in the leukocytes of the patients were variable. In most instances no arginine was found. However, in a few patients (G1, G11, L1, L6) high concentrations of arginine were found (roughly 1,000,umoles per kg water).
No significance can be attributed to this finding, since similar irregular arginine values had been found in two of the leukocyte analyses of normal subjects ( 1 ) . Table IV . High concentrations of glutamic acid, 0-phosphoethanolamine and proline, and a low concentration of ornithine, all of which have been already found in most leukemic patients, were the only differences from normal subjects noted in these analyses. Furthermore, when examined with respect to the types of leukemia grouped in Table IV (chronic granulocytic leukemia, acute granulocytic leukemia, subacute granulocytic leukemia and monocytic leukemia) there were no patterns that could be associated with any one type of leukemia. Treatment of the patients by Myleran, 6-mercaptopurine, Meticorten, testosterone or spray X-ray of the spleen five days before the analysis caused no recognizable changes in amino acid concentrations in the leukocytes of this group of patients.
The packed-cell volumes of the leukocytes of the granulocytic and monocytic patients were found to be similar to those of normal subjects. Platelet contamination occurred to an appreciable extent in analyses G2 and G3 (25 platelets to approximately 1 leukocyte). Comparison of the amino acid concentrations found in platelets 6 with those in leukocytes showed that this contamination would not have affected the leukocyte values by more than 15 per cent and no allowance was made for it. One would expect the error induced by platelet contamination to be largely compensated for in the packed-cell volume measurements which were used to express the concentration of the amino acids and which included the volumes of both the platelets and the leukocytes. b) Untreated chronic lymphocytic leukemia. Table V presents the results of 11 analyses of leukocytes from 10 patients with chronic lympho-cytic leukemia who had not had chemotherapy or X-ray treatments, or who had not had such treatment for a period of four months preceding the assay. Only alanine, proline, tyrosine and probably arginine were at concentrations comparable with those in the leukocytes of normal subjects. Glutamic acid, 0-phosphoethanolamine and ethanolamine were at very high concentrations. Excluding these seven substances the average concentrations of the remaining amino acids were 50 per cent less than those of normal subjects. Glutamine concentration was only 40 per cent of that found in normal leukocytes. This substance was also found to be slightly lower in the erythrocytes of the leukemic patients, but it was not lower in the leukocytes of granulocytic and monocytic leukemias (category a) Rouser (4) dichloro-N-methyldiethylamine, Merck). The assays of these patients are listed in Table VI . As previously noted, the high concentrations of O-phosphoethanolamine typical of the untreated chronic lymphocytic leukemias were not uniformly found in this group of patients. Furthermore, glutamic acid was not as high in the leukocytes of this group as in other leukemic patients. Other amino acids showed large variations in concentration which appeared to be influenced by the type of treatment and period of time after treatment. A discussion of these effects in each of these patients follows. In the leukocytes of two patients (assays Li and L6) shortly after treatment with Chlorambucii, concentrations of amino acids were considerably higher than those found in untreated patients. Thus, in assay LI, from Patient H.B. on the tenth day after the start of a three week course of Chlorambucil, amino acid concentrations were approximately 40 per cent higher than those of untreated chronic lymphocytic patients. With the exception of histidine, ornithine, and threonine, whose concentrations were low, the unbound amino acid concentrations for this assay were comparable with the concentrations in leukocytes of normal subjects. In analysis L6, taken from Patient A.J.R. on the nineteenth day after completion of a three week course of Chloroambucil, a very marked increase in the unbound amino acid concentrations was observed. The values were much higher than the concentrations which had been found for untreated chronic lymphocytic leukemics and were higher than 2 SD from the means from normal leukocytes in all substances except for glutamic acid, glutamine, taurine and O-phosphoethanolamine. The white cell counts of both of these patients had been brought down by the treatment from high to normal levels. The Two analyses from one patient were taken 44 days (assay L3) and 75 days (assay L4) after completion of different series of Chloroambucil treatment (see Table VI ). The unbound amino acid concentrations found in each were either as low as or lower than the concentrations found in untreated patients. Presumably the critical stage of elevated amino acid concentrations following treatment had passed. However, the response of this patient to Chlorambucil had not been satisfactory as far as white count depression was concerned. Analysis L3 was unique in that it showed the lowest unbound amino acid concentration ever found. The average concentration was approximately one-fourth that found in normal leukocytes. Glutamine was normal and ethanolamine was elevated. The unbound amino acid analyses of the urine for this assay were also very low. The white count was 67.000 per mm3 for analysis L3 and 56,000 per mm3 for analysis L4. The cell type in both analyses was essentially all lymphocytic.
One assay (L14) was conducted on a patient on the twelfth day following completion of treatment with TEM, and another assay (L17) was conducted on a patient who had had treatment with nitrogen mustard on the eighteenth, seventeenth and fourth days prior to the assay. The results of these assays are listed in Table VI. 0-phosphoethanolamine was elevated in the leukocytes of both of these patients, glutamic acid was elevated in one. Other amino acid concentrations were irregular but usually higher than those found in untreated chronic lymphocytic leukemic patients. A different response to treatment by Chlorambucil and these two compounds in relation to O-phosphoethanolamine and glutamic acid reduction is thus implied although the number of subjects involved is very small. d) Chronic lymphocytic leukemia after X-ray treatment. A patient with chronic lymphocytic leukemia and large deposits of lymphosarcoma had two tests conducted in association with X-ray treatment and a third test conducted well after the period of X-ray treatment; Table VII lists the leukocyte and urine values for these analyses. The first analysis was made on the day after the first exposure to 20 r units of total body radiation. Alanine, glutamic acid, taurine and O-phosphoethanolamine concentrations in the leukocytes were elevated 5-, 20-, 4-and 20-fold, respectively, above the mean of normal subjects as well as above that of the untreated lymphocytic leukemic patients. Several of the other amino acids were moderately elevated, whereas only histidine and ornithine were low. After completion of the first course of X-ray treatment, the white cell counts of the patient were reduced from 487,000 to 9,500 per mm3 in three months, but the masses of lymphosarcoma in various areas of the lymph nodes were not much reduced. A second course of X-ray consisting of 40 r units per treatment to large areas of the body, but not total body radiation, was given on the sixth, fourth, third and second days prior to the second analysis. Some reduction in the quantity of the amino acids in very high concentrations was noted when compared with the earlier anal)--sis. However, alanine, glutamic acid, leucine plus isoleucine, lysine, threonine, and serine plus glycine were elevated approximately twofold above the normal range and 0-phosphoethanolamine was elevated eightfold. On the third analysis, 135 days following the second course of X-ray treatment, and with no intervening treatment of any kind except transfusions, the leukocyte levels had returned to the state of the typical untreated chronic lymphocytic leukemia. The elevated amino acid concentrations in the leukocytes following X-ray treatment were not influenced by the magnitude of the white cell count as these differed enormously: 490,000, 9,500 and 22,000 per mm3 for bloods from analyses L7, L8 and L9, respectively. No changes occurred in cell type following X-ray (all lymphocytes). The packed-cell volumes of the leukocytes in these assays were not significantly larger than the packed-cell volumes of lymphocytic leukemic patients who had not had X-ray irradiation. This does not agree with the increases in cell volumes observed by others following in vivo irradiation of Yoshida sarcoma cells in rats (10) or Ehrlich carcinoma cells in mice (11) .
Except for an increased concentration of urea I Counts per mm3 X 10-3 of whole blood.
in the plasma and erythrocytes, and an increased concentration of glutamic acid in the erythrocytes, irradiation did not affect the unbound amino acids in the blood compartments other than the leukocytes. High concentrations of phenylalanine and ornithine were observed in the plasma and erythrocytes of this patient (S.G.) without regard to the time the assay was conducted after irradiation, and therefore these elevated values do not appear to be associated with radiation exposure. Katz and Hasterlik (12) found, in a study of individuals accidentally exposed to varying amounts of total body irradiation, that while aminoaciduria was evident 12 hours after exposure the peak excretion was not reached until the sixth day. Kay, Early and Entenman (13), however, had observed a peak excretion of taurine and urea in rats five hours after irradiation. In the curent study, in which exposure to irradiation had occurred approximately 24 hours prior to assay L7 and approximately 48 hours prior to assay L8, taurine excretion rates were very high in both assays, and urea, glutamine, and ethanolamine excretion rates were moderately high. Of considerable interest in this study was the correlation between the high excretion rates and high concentrations of some compounds in the plasma, erythrocytes and leukocytes following the X-ray exposure. Thus the high excretion rate of taurine corresponded to high concentrations of taurine in the leukocytes. High excretion rates of glutamine corresponded to high concentrations of glutamic acid (the precursor for the glutamine excreted in the urine) in the leukocytes and erythrocytes. High excretion rates of ethanolamine in assay L7 corresponded to a very high concentration of 0-phosphoethanolamine in the leukocytes (0-phosphoethanolamine is presumably hydrolyzed to give ethanolamine). Finally, high excretions of urea corresponded to high concentrations of urea in the plasma and erythrocytes. what moderate increases in excretion of the other amino acids. An unusual feature of this patientwas that in an analysis 74 days earlier, and with no apparent intervening change having taken place in the patient's condition, a normal excretion rate for all substances was found (assay L10). Proline and valine, which were usually not found in the urines of normal subjects, were excreted in increased amounts by some of the patients.
A rather unusual finding was the low excretion rate for ethanolamine in six urines of patients with chronic lymphocytic leukemia. Ethanolamine was elevated in the plasma and erythrocytes of some of the patients. However, except for an analysis following X-ray exposure, ethanolamine was never excreted by the patients in amounts greater than those excreted by normal subjects. This suggests that ethanolamine is being utilized in some manner, perhaps associated with O-phosphoethanolamine formation, rather than being excreted. The possibility of the excretion of etha- nolamine in a complex form was not investigated. In any event, the results of this study strongly support a disturbed ethanolamine and 0-phosphoethanolamine metabolism in the leukemic patients. /3-Amino isobutyric acid, which was found infrequently in our analyses of normal subjects (1), was found in moderate amounts in urine assays LI and L3; both patients had had treatment with Chlorambucil. In some of our assays an unidentified ninhydrin-positive substance in very high concentration interfered with the estimation of /l-amino isobutyric acid. Fink, Henderson and Fink (14) first reported the presence of /3-amino isobutyric acid in urine. These workers noted that its concentration was occasionally very high in cancer patients and apparently related to the neoplastic process. Awapara (15) found /3-amino isobutyric acid to be excreted in large amounts in the urines of leukemic patients treated with nitrogen mustard, provided the analysis coincided with a particular time interval after the treatment.
DISCUSSION
In all four of the body compartments of leukemic patients (that is, plasma, erythrocytes, leukocytes, and urine) differences from normal subjects have been found to exist. These are reported in some detail in the preceding section. For brevity and easy reference the principal findings in each compartment are also tabulated in Table IX . It is important to recognize that while some changes were reflected simultaneously in two compartments, e.g., increase in glutamic acid and proline in both erythrocytes and leukocytes of the leukemic patients, other changes occurred in only one specific compartment, e.g., increase in serine plus glycine in the erythrocytes, increases of ornithine in the erythrocytes, or decreases of ornithine in the leukocytes. By virtue of these different responses, it must be concluded that in leukemia each of the fluid compartments is affected in a different manner.
One may speculate at some length on the significance of the complex changes observed in the leukemic patients. One of the most striking, and certainly one which appears to be common to the neoplastic process, since it is also found in other malignancies (7, 8) , is the elevated cell glutamic acid concentration. In the present study high glutamic acid was observed not only in the leukocytes but also in the erythrocytes. is a congener of glutamic acid or in transamidation where glutamic acid is involved, or it may be the result of some unknown defect.
Equally less well understood in its role is the increase of 0-phosphoethanolamine in the leukocytes. This substance has also been reported elevated in malignant tissues by others (6) . Because it is to a large extent normally fixed in the structure of the cell lipid, the increase may be the result of more rapid turnover of the leukemic as compared with normal cells. The increase in O-phosphoethanolamine concentration in the leukemic white cells is so marked that its use for the diagnosis of leukemia may be feasible. It is of additional interest that both glutamic acid and 0-phosphoethanolamine are reduced in concentration in the remission following treatment with Chlorambucil.
A number of changes in concentrations of other substances were noted. Certainly the marked reduction of ergothioneine in the chronic granulocytic leukemic patients should be further investigated. Also, the finding of increased concentrations of amino acids in the leukocytes following extensive body radiation is of much interest. In the latter investigations only small changes were observed in the plasma and erythrocytes, which suggests that the leukocytes may be the more susceptible to radiation damage.
SUMMARY
Interrelationships among the amino acid concentrations in the blood cells, plasma and urine of patients with chronic granulocytic, chronic lymphocytic, acute granulocytic, subacute granulocytic and monocytic leukemia have been studied.
When compared with normal subjects the following significant differences were observed.
1. Findings common to all the leukemic patients: a) In the plasma, ornithine, ethanolamine and urea were high, alanine was low. b) In the erythrocytes, ornithine, proline, ethanolarnine, serine plus glycine, and urea were high. c) In the leukocytes, 0-phosphoethanolamine, glutamic acid and proline were high, ornithine was low. Proline was high in the leukocytes of the chronic lymphocytic leukemic patients only when compared relative to the other amino acids. d) Ornithine and urea 
